14 research outputs found

    Chronotropic action of immobilized subtilisins during the perfusion of an isolated rat heart

    Get PDF
    The pharmacological experiments on isolated organs (ex vivo) are the preferred method for assessing the primary pharmacodynamics of the studied drugs, since this method is completely excluded the systemic influence of neurohumoral regulation. In the last decade, a new group of thrombolytic drugs based on immobilized subtilisins has been formed. At the stage of registrational preclinical and clinical studies, their pleiotropic pharmacological effects have not been studied. Meanwhile, there is a reason to consider that their pharmacological activity in the bloodstream is not limited to thrombolytic action, but may be extended to a systemic effect on the cardiovascular system.Β The aim of the study was to investigate the chronotropic effects of an isolated heart during its perfusion with solutions of immobilized subtilisins at different concentrations.Β Material and methods. The isolated rat heart model according to Langendorff was used in the study. The experiment included 50 Wistar rats, which were divided into 5 groups: isolated hearts perfused only with Krebs – Henseleit solution (control) or with immobilized subtilisins in 4 concentrations (170, 340, 510 ΠΈ 1020 U/l).Β Results and discussion. The immobilized subtilisins have a negative chronotropic effect. The onset of the effect depends on the drug concentration in the solution: the higher concentration, the earlier effect. From 5 to 10 minutes of perfusion, a negative chronotropic effect is observed using of immobilized subtilisins at any dose. The duration of its increase is manifested up to 10–20 minutes, depending on the drug concentration in solution. After 20 minutes of perfusion, the achieved negative chronotropic effect remains at a plateau level up to 40 minutes.Β Conclusion. The immobilized subtilisins have an independent pharmacological effect on heart rate

    Studying the pharmacokinetic parameters of new normothymic drug based on the complex of lithium citrate, aluminum oxide and polymethylsiloxane

    Get PDF
    For the treatment of bipolar affective disorders, lithium preparations are the most famous and effective. But the main problem with the use of lithium preparations is the narrow Β«therapeutic corridorΒ». An urgent task is the creation of dosage forms of lithium with a slow release and a wide therapeutic range. The study object was a new normotymic drug based on lithium, aluminum oxide and polymethylsiloxane. Due to the new carrier matrix lithium is released from its porous structure gradually providing a prolonged effect and maintaining an optimal concentration in the blood which also helps to minimize side effects. The purpose of the study was to explore the pharmacokinetic parameters of a normotymic drug based on a complex lithium citrate, aluminum oxide and polymethylsiloxane (LOAP).Material and methods: for the assessment of pharmacokinetic parameters the method of atomic emission spectrometry with inductively coupled plasma and two-chamber modeling were used.Results and discussion. The pharmacokinetic data showed a linear nature of pharmacokinetics of the drug based on LOAP as the foundation of data of the lithium’s amount in the blood plasma of rabbits after intragastric administration at doses of 200, 400 and 800 mg/kg. The drug with intragastric administration at a dose of 800 mg/kg is well absorbed from the gastrointestinal tract, with bioavailability (F) 74 %. This dose shows the maximum increase of the area under the pharmacokinetic curve (AUC - 32787.1 (ng x h)/ ml), and indicators of elimination constant (Kel - 0.062 h-1), clearance (Cl - 0.09 l/(kg x h)), elimination half-life (T1/2p - 11.436 h) in comparison with other doses remain unchanged

    GENDER DIFFERENCES OF ANTHROPOMETRIC CHARACTERISTICS, APPROPRIATE HEART RATE AND THE STRESS RESISTANCE INDEX OF EARLY ADOLESCENTS LIVING ON THE TERRITORY OF KRASNODAR KRAI AND THE REPUBLIC OF KABARDINO-BALKARI

    Get PDF
    Aim. To find out gender features of anthropometric characteristics, to define average index value of stress resistance of young teenagers living on the territory of Krasnodar Krai and the Republic of Kabardino-Balkaria.Materials and methods. Data on body height, weight, arterial blood pressure and pulse of 140 children (70 girls and 70 boys) at the age of 13,2Β±1,6 years living in the Republic of Kabardino-Balkaria as well as 137 children (70 boys and 67 girls) at the age of 13,4Β±0,1 year living on the territory of Krasnodar Krai (The Belorechensk and Crimean Districts) are collected and subjected to the statistical analysis. The appropriate number of heartbeat, total body area, the level of endured stress were determined by the formulas developed by Yu.R. Sheykh-Zade. Digital material is processed by the method of variation statistics in the Microsoft Excel program.Results. The carried-out statistical analysis showed that anthropometric parameters are lower in thirteen-year old boys living in the Republic of Kabardino-Balkaria than in inhabitants of various parts of Krasnodar Krai: body weight (47,63Β±1,75 and 52,56Β±1,02 kg respectively), body area (14279,54Β±176,54 and 15109,95Β±181,67 cm2 respectively), index of body weight (19,12Β±0,21 and 20,43Β±0,30 c.u. respectively). Girls at the age of thirteen living in the Republic of KabardinoBalkaria have lower physiological parameters in comparison with inhabitants of Krasnodar Krai: the appropriate number of heartbeat (68,31Β±0,54 and 70,78 Β±0,39 min-1 respectively), stress resistance index (1,14Β±0,23 and 1,28Β±0,05 c.u. respectively).Conclusion. Gender differences of anthropometric and physiological parameters in children of the early teenage period between the stated regions (Krasnodar Krai and the Republic of Kabardino-Balkaria) are determined

    Анализ взаимосвязи ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΎΠ² Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ с Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒΡŽ клиничСских проявлСний Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… хроничСской обструктивной болСзнью Π»Π΅Π³ΠΊΠΈΡ…: возмоТности лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ

    Full text link
    Objective: to assess pulmonary hemodynamics and the presence of systolic and/or diastolic dysfunction of the myocardium of the right and left ventricles in patients with COPD, depending on the risk groups (A, B, C, D); to determine the possible directions of pharmacological correction.Methods. Patients (n = 119, including 87 men, mean age - 62.5 Β± 14.8 years) with COPD of risk group A (n = 21) and B (n = 98) (GOLD, 2019). In addition to the routine clinical and instrumental examinations, pulmonary and aortic pulse wave velocity was determined using MRI diagnostics.Results. The right ventricular diastolic dysfunctions (DD) were revealed in all patients with COPD (E/A TV = 0.85 Β± 0,03 vs 0.97 Β± 0,03; groups A and B respectively, p < 0,05). 28.6% of patients of group B had a restrictive type of transtricuspid blood flow (p < 0,05). The pulmonary blood pressure was increased: 24.3 Β± 7.6 mm Hg in patients with COPD group A, 17.2 Β± 6.8 mm Hg - in group B. Patients of group B had a higher pulmonary pulse wave velocity (pPWV) (B: 3.13 [2.93-3.44] ms-1 vs A: 1.97 [1.62-2.68] ms-1, p = 0.005) and stroke volume of RV (B: 33.5 [27.3-37.9] mL vs A: 29.1 [24.0-35.7] mL, p = 0.005). The correlation between pPWV and the degree of bronchial obstruction, ejection fraction and end-diastolic volume of the RV, and mean pulmonary arterial pressure (mPAP) was strong for patients of group B and moderate for patients of group A.Conclusion. Thus, patients with COPD risk group A have the borderline indicators of mPAP with DD of LV and RV. The progression of hemodynamic disorders is associated with the aggravation of of clinical symptoms and respiratory disorders, that were more pronounced in group B. This progression led to mandatory broncholytic drug correction.ЦСлью Ρ€Π°Π±ΠΎΡ‚Ρ‹ явилась ΠΎΡ†Π΅Π½ΠΊΠ° Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΈ наличия систоличСской ΠΈ / ΠΈΠ»ΠΈ диастоличСской дисфункции (Π”Π”) ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π° ΠΏΡ€Π°Π²ΠΎΠ³ΠΎ (ΠŸΠ–) ΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ (Π›Π–) ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ² Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… хроничСской обструктивной болСзнью Π»Π΅Π³ΠΊΠΈΡ… (Π₯ΠžΠ‘Π›) Π² зависимости ΠΎΡ‚ принадлСТности ΠΊ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π³Ρ€ΡƒΠΏΠΏ риска (ABCD) согласно классификации Π“Π»ΠΎΠ±Π°Π»ΡŒΠ½ΠΎΠΉ стратСгии диагностики, лСчСния ΠΈ ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ Π₯ΠžΠ‘Π› (Global Initiative for Chronic Obstructive Lung Disease β€” GOLD, 2019) Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹Ρ… Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½Ρ‚ΠΎΠ·Π½ΠΎΠΉ ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΠΈ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠžΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ‹ Π±ΠΎΠ»ΡŒΠ½Ρ‹Π΅ Π₯ΠžΠ‘Π› (n = 119, 87 ΠΌΡƒΠΆΡ‡ΠΈΠ½; срСдний возраст - 62,5 Β± 14,8 Π³ΠΎΠ΄Π°) Π³Ρ€ΡƒΠΏΠΏ риска А (n = 21) ΠΈ Π’ (n = 98) ΠΏΠΎ GOLD (2019). Помимо общСпринятых ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΈΠ½ΡΡ‚Ρ€ΡƒΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½Ρ‹Ρ… обслСдований, ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡŒ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π°ΠΎΡ€Ρ‚Π°Π»ΡŒΠ½ΠΎΠΉ ΠΈ Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠΉ скорости распространСния ΠΏΡƒΠ»ΡŒΡΠΎΠ²ΠΎΠΉ Π²ΠΎΠ»Π½Ρ‹ (Π»Π‘Π ΠŸΠ’) с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΌΠ°Π³Π½ΠΈΡ‚Π½ΠΎ-рСзонансной Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΈΠΈ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π£ всСх Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π₯ΠžΠ‘Π› выявлСны Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ Π² Π²ΠΈΠ΄Π΅ Π”Π” ΠŸΠ– (ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠ΅ максимальной скорости Ρ€Π°Π½Π½Π΅Π³ΠΎ диастоличСского наполнСния ΠΊ максимальной скорости прСдсСрдного диастоличСского наполнСния (Π• / ΠΠŸΠ–) Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска А составило 0,85 Β± 0,03 vs 0,97 Β± 0,03 - Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’;Ρ€ < 0,05). Π£ 28,6 % Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’ (Ρ€ < 0,05) опрСдСлялся рСстриктивный Ρ‚ΠΈΠΏ Ρ‚Ρ€Π°Π½ΡΡ‚Ρ€ΠΈΠΊΡƒΡΠΏΠΈΠ΄Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΊΡ€ΠΎΠ²ΠΎΡ‚ΠΎΠΊΠ°. ЛСгочная гипСртСнзия Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π₯ΠžΠ‘Π› Π³Ρ€ΡƒΠΏΠΏΡ‹ риска А составила 24,3 Β± 7,6 ΠΌΠΌ Ρ€Ρ‚. ст., Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’ - 17,2 Β± 6,8 ΠΌΠΌ Ρ€Ρ‚. ст. Π£ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’ ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Ρ‹ Π±ΠΎΠ»Π΅Π΅ высокиС значСния Π»Π‘Π ΠŸΠ’ (3,13 (2,93-3,44) мс-1 vs 1,97 (1,62-2,68) мс-1 Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска A; Ρ€ = 0,005) ΠΈ ΡƒΠ΄Π°Ρ€Π½ΠΎΠ³ΠΎ объСма ΠŸΠ– (33,5 (27,3-37,9) ΠΌΠ» Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’ vs 29,1 (24,0-35,7) ΠΌΠ» - Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска А; Ρ€ = 0,005). УстановлСна сильная коррСляция ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π»Π‘Π ΠŸΠ’ со ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒΡŽ Π±Ρ€ΠΎΠ½Ρ…ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ обструкции, Ρ„Ρ€Π°ΠΊΡ†ΠΈΠΈ выброса ΠΈ ΠΊΠΎΠ½Π΅Ρ‡Π½ΠΎΠ³ΠΎ диастоличСского объСма ΠŸΠ–, срСднСго давлСния Π² Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ (ДЛАср.) Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π³Ρ€ΡƒΠΏΠΏΡ‹ Π’ ΠΈ ΡƒΠΌΠ΅Ρ€Π΅Π½Π½ΠΎΠΉ силы коррСляция - Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска А.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π₯ΠžΠ‘Π› Π³Ρ€ΡƒΠΏΠΏΡ‹ риска А ΠΏΠΎ GOLD (2019) ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‚ΡΡ ΠΏΠΎΠ³Ρ€Π°Π½ΠΈΡ‡Π½Ρ‹Π΅ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ ДЛАср. с Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ΠΌ Π”Π” ΠŸΠ– ΠΈ Π›Π–. ΠŸΡ€ΠΎΠ³Ρ€Π΅ΡΡΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ гСмодинамичСских Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ связано с утяТСлСниСм клиничСских проявлСний ΠΈ Π΄Ρ‹Ρ…Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… расстройств, Π±ΠΎΠ»Π΅Π΅ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½Ρ‹Ρ… Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π³Ρ€ΡƒΠΏΠΏΡ‹ риска Π’, ΠΏΡ€ΠΈ этом трСбуСтся ΠΎΠ±ΡΠ·Π°Ρ‚Π΅Π»ΡŒΠ½Π°Ρ бронхолитичСская мСдикамСнтозная коррСкция
    corecore